Hornet Therapeutics is a biotech company focused on developing treatments to address Epstein-Barr Virus (EBV) driven pathologies. The Company was founded by 4BIO Capital and Professor Christoph Hess, based on breakthrough work from Christoph Hess’s lab on translational aspects of lymphocyte function and its metabolic basis. Whilst in incubation, the Company established pioneering single gene-level precision engineering of immune cell metabolism to induce or abolish specific cellular states.

Hornet Therapeutics

Org chart

Teams

Offices